Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(8%)
Results Posted
33%(3 trials)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
3
23%
Ph early_phase_1
1
8%
Ph phase_2
5
38%
Ph phase_3
3
23%

Phase Distribution

2

Early Stage

5

Mid Stage

3

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
5(38.5%)
Phase 3Large-scale testing
3(23.1%)
N/ANon-phased studies
3(23.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(9)
Terminated(1)
Other(1)

Detailed Status

Completed9
unknown1
Enrolling by invitation1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (7.7%)
Phase 11 (7.7%)
Phase 25 (38.5%)
Phase 33 (23.1%)
N/A3 (23.1%)

Trials by Status

unknown18%
enrolling_by_invitation18%
recruiting18%
completed969%
withdrawn18%

Recent Activity

1 active trials
Showing 5 of 13
enrolling_by_invitationearly_phase_1

Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study

NCT06419335
recruitingphase_3

CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease

NCT05422534
completednot_applicable

Pharmacokinetics of Different CoQ10 Formulations

NCT06151171
withdrawnphase_3

Efficacy of Coenzyme Q10 Supplementation on Multi-Organ Dysfunction in Severely Burned Patients

NCT03968640
completedphase_2

Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease

NCT03579693
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT06419335Early Phase 1

Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study

Enrolling By Invitation
NCT05422534Phase 3

CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease

Recruiting
NCT06151171Not Applicable

Pharmacokinetics of Different CoQ10 Formulations

Completed
NCT03968640Phase 3

Efficacy of Coenzyme Q10 Supplementation on Multi-Organ Dysfunction in Severely Burned Patients

Withdrawn
NCT03579693Phase 2

Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease

Completed
NCT00976131Phase 1

Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer

Completed
NCT03133793Phase 2

CoQ10 and D-ribose in Patients With Diastolic Heart Failure

Completed
NCT00532571Phase 2

Effects of Coenzyme Q10 in PSP and CBD

Completed
NCT02119117Not Applicable

Aneuploidy Rates in Advanced Maternal Age Patients Supplemented With Coenzyme Q10 (CoQ10) Versus Those That Are Not: a Pilot Study

Completed
NCT02333305Phase 3

Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10

Completed
NCT00920699Phase 2

Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)

Completed
NCT02218476Not Applicable

Beneficial Effects of Coenzyme Q10 Treatment on the Mitochondrial Dysfunction and Oxidative Stress Associated to Atherothrombosis Developement in Antiphospholipidid Syndrome Patients

Unknown
NCT00076492Phase 2

NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485

Completed

All 13 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
13